Delivery Order SPE2DB20D7059-SPE2DB24FPXN6

Award Date 1/12/24
Potential Completion Date 1/16/24
Potential Value $1.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the delivery of the pharmaceutical product "LORYNA 3 MG-0.02 MG TABLET 28S" with a ceiling value of $1,450.40. The contract is a firm fixed price delivery order with a period of performance through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $5,219.92, is for the delivery of the medication "LORYNA 3-0.02MG 84S" and has an ultimate completion date of January 16, 2025. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,005.92 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to provide LORYNA 3 MG-0.02 MG TABLET 28S, a pharmaceutical product, with a completion date of February 23, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 and running through December 31,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of LORYNA 3 MG-0.02 MG TABLET 28S, a pharmaceutical product, with a ceiling value of $1,388.10 and a period of performance through July 12, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,629.25, is for the supply of LORYNA 3 MG-0.02 MG tablets in 28-count packages. The delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of the pharmaceutical product "LORYNA 3-0.02MG 84S" and has a ceiling value of $4,289.40. The contract is a firm fixed price delivery order, with an ultimate completion date of April 17, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,332.50, is for the supply of Loryna 3 mg-0.02 mg tablets, a prescription medication. The contract has an ultimate completion date of January 13, 2023 and is a firm fixed-price type. The contract is not designated as a set-aside and was awarded under the DLA's Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,091.45, is for the delivery of LORYNA 3 MG-0.02 MG tablets, a pharmaceutical product. The contract has an ultimate completion date of September 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $1,003.20, is a firm fixed-price delivery order for the pharmaceutical product LORYNA 3 MG-0.02 MG TABLET 28S. The contract has an ultimate completion date of November 7, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that provides a comprehensive range of medical products to federal agencies, particularly within...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,133.10, is for the delivery of the pharmaceutical product LORYNA 3 MG-0.02 MG TABLET 28S. This is a firm fixed-price delivery order contract with a completion date of November 16, 2023. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
  • SPE2DB20D7059
    Indefinite Delivery Contract
  • SPE2DB20D7059-SPE2DB24FPXN6
    Delivery Order

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical distribution company. The contract is for the supply of the pharmaceutical product LORYNA 3 MG-0.02 MG TABLET 28S, with a potential value of $1,450.40 and a completion date of January 16, 2024. This delivery order is issued under an indefinite delivery contract (IDC) previously awarded by DLA to Amerisourcebergen Drug Corp, with a maximum potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order does not have a set-aside designation.

Generated 4/30/24, 7:14 PM